The Pfizer/BioNTech coronavirus disease 2019 vaccine can be stored at higher temperatures; the Biden administration pledges $4 billion over 2 years to Gavi, the Vaccine Alliance; Medicare payments will soon decrease for hundreds of hospitals.
New coronavirus disease 2019 (COVID-19) vaccine storage and effectiveness data from Sheba Medical Center in Israel show that the first dose of Pfizer/BioNTech’s vaccine is 85% effective 15 to 28 days after it is given, reports The Wall Street Journal. Transportation and storage at temperatures of –25°C (–13°F) to –15°C (5°F), vs the current –80°C (–112°F) to –60°C (–76°F), are also possible according to the real-world data. These findings could enable more to get an initial dose of the vaccine, as the results “provide strong arguments in favor of delaying the second dose of the 2-shot vaccine,” the authors note. Close to 9000 individuals were covered in this study, in which the first dose also resulted in 75% reductions in symptomatic and asymptomatic infections.
Up to $4 billion in funding for Gavi, the Vaccine Alliance, could be possible through a new push from President Joe Biden and his administration, according to The Washington Post. This money would provide some much-needed aid to COVID-19 Vaccines Global Access, or COVAX, which has yet to begin vaccine delivery. An initial $2 billion would be released first, followed by another $2 billion over 2 years, pending pledge follow-through from other potential donors. The World Health Organization and the Coalition for Epidemic Preparedness Innovations are Gavi’s partners in this effort to ensure equitable vaccine distribution to low- and middle-income countries.
High patient infection rates and avoidable medical complications from mid-2017 through 2019 have spurred the government’s move to reduce Medicare payments to 774 hospitals, says Kaiser Health News. The 1% reduction, as part of a program instituted by the Affordable Care Act, will be implemented over 12 months and is not related to the ongoing pandemic. Controversy has plagued the Hospital-Acquired Condition Reduction Program since its inception, with hospitals claiming penalties are arbitrary and the American Hospital Association saying the hard-and-fast rule of punishing 25% of general-care hospitals each year is a flawed measure.
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen